Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Histone H3.3 Protein (G34V, Nucleosome)

Cette protéine Recombinant Histone H3.3 est produite dans Escherichia coli (E. coli).
N° du produit ABIN7938947
616,92 €
Frais d'envoi 40,00 €, glace carbonique 20,00 € et TVA exclus
20 μg
Destination: France
Envoi sous 2 à 4 jours ouvrables

Aperçu rapide pour Histone H3.3 Protein (G34V, Nucleosome) (ABIN7938947)

Antigène

Voir toutes Histone H3.3 (H3F3A) Protéines
Histone H3.3 (H3F3A) (H3 Histone, Family 3A (H3F3A))

Type de proteíne

Recombinant

Origine

  • 51
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Source

  • 50
  • 9
  • 1
Escherichia coli (E. coli)

Application

Screening Assay (ScA), Enzyme Kinetics (EK)

Pureté

>95 % pure by SDS-PAGE
  • Attributs du protein

    G34V, Nucleosome

    Fonction

    Recombinant Polynucleosomes H3.3 (G34V)

    Attributs du produit

    Recombinant Human Polynucleosomes (G34V) protein contains a Gly34Val point mutation. Nucleosomes comprise the smallest subunit of chromatin, they consist of 147 bp of DNA wrapped around an octamer of core histone proteins (H2A, H2B, H3 and H4). Therefore, nucleosomes are more physiologically relevant substrates than histones and histone-derived peptides for use in in vitro studies. More importantly, some histone methyltransferases are significantly more active, as well as specific, when using nucleosomal substrates in HMT assays, such as DOT1L and NSD family enzymes. Nucleosomes are also widely used in histone methyltransferase screening assays to identify small molecular inhibitors for drug discovery.
  • Vous souhaitez d'autres options pour ce Protein ?

    !
    Découvrez nos protéines personnalisées prédéfinies et nos services de protéines sur mesure !

    Votre projet nécessite-t-il une personnalisation supplémentaire ? Contactez-nous et découvrez nos solutions protéiques sur mesure

  • Indications d'application

    Recombinant Polynucleosomes H3.3 (G34V) are suitable as substrate for use in the study of enzyme kinetics, inhibitor screening, and selectivity profiling.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Human Recombinant Polynucleosomes H3.3 (G34V) (20 μg protein+ 24 μg DNA) are supplied in 10 mM Tris pH 8.0, 1 mM EDTA, 2 mM DTT, 20 % glycerol.

    Agent conservateur

    Dithiothreitol (DTT)

    Précaution d'utilisation

    This product contains Dithiothreitol (DTT): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeated freeze/thaw cycles,keep on ice when not in storage

    Stock

    -80 °C

    Stockage commentaire

    Recombinant proteins in solution are temperature sensitive and must be stored at -80°C to prevent degradation. Avoid repeated freeze/thaw cycles and keep on ice when not in storage.
  • Antigène

    Histone H3.3 (H3F3A) (H3 Histone, Family 3A (H3F3A))

    Autre désignation

    Histone H3.3

    Sujet

    Protein Background: In vivo, the nucleosome is the basic structural unit of chromatin. It is comprised of about 146 bp of DNA wrapped around a core of eight histones of four different types: H2A, H2B, H3 and H4. Histones are subject to posttranslational modifications, such as methylation, acetylation, phosphorylation and mono-ubiquitination. Histone modifications influence multiple chromatin-templated processes such as gene transcription, DNA repair and recombination. Besides the ""major"" histones, there are some histone variants in specific regions of chromatin or in specific cell types. Histone variants are involved in multiple processes including chromosome segregation, DNA repair, transcriptional regulation and mRNA processing. Histone H3.3 point mutations (K27 and G34) are found in 1/3 of pediatric glioblastomas. Up to 78 % of diffuse intrinsic pontine gliomas (DIPGs) carry K27M and 36 % of non-brainstem gliomas carry either K27M or G34R/V mutations. High- frequency mutation of histone H3 to K36M is observed in chondroblastomas, as is the mutation G34W/L in giant cell tumors of bone, diseases of adolescents and young adults. Histone H3.3 mutations drive pediatric glioblastoma through upregulation of MYCN. Nucleosomes are more physiologically relevant substrates than histones and histone-derived peptides for in vitro studies. More importantly, some histone methyltransferases are significantly more active, as well as specific, when using nucleosomal substrates in HMT assays, such as DOT1L and NSD family enzymes. Nucleosomes are also widely used in histone methyltransferase screening assays to identify small molecular inhibitors for drug discovery.

    Short Description: Recombinant Polynucleosomes H3.3 (G34V), Human, consist of 5000 bp of DNA (plasmid pG5E4) and two molecules each of histones H2A that includes amino acids 1-130 (end) (accession number NM_003512), H2B that includes amino acids 1-126 (end) (accession number NM_003518), H3.3 that includes amino acids 1-136 (end) (accession number NM_005324) with a point mutation Gly34Val, and H4 that includes amino acids 1-103 (end) (accession number NM_003548). Plasmid pG5E4 contains 9 of 5S rDNA nucleosome positioning sequences of L. variegatus, 5 of GAL4 binding sites and E4 promoter. Every 5S rDNA can wrap one histone octamer to form a nucleosome. 5 of GAL4 binding sites and E4 promoter can wrap histone octamers to form dinucleosomes. A pG5E4 plasmid can warp histone octamers to form 11 nucleosomes. The recombinant protein is >95 % pure by SDS-PAGE.

    Aliases: Histone H3.3, Histone H3, H3, G34V

Vous êtes ici:
Chat with us!